Assignee
MERCK SHARP & DOHME LLC
US·200 granted patents·266 pending applications·96 citations·filing 2013–2025
Top patents by PatentIndex Score
466 records- 0196US12220408B2Treatment of migraineMERCK SHARP & DOHME LLC·Filed 2024·Granted Feb 11, 2025·5 cites·30 claims
- 0296US12168004B2Treatment of migraineMERCK SHARP & DOHME LLC·Filed 2024·Granted Dec 17, 2024·5 cites·30 claims
- 0395US12310953B2Pharmaceutical formulations for the treatment of migraineMERCK SHARP & DOHME LLC·Filed 2024·Granted May 27, 2025·3 cites·30 claims
- 0495US12180219B2Process for preparing beta 3 agonists and intermediatesMERCK SHARP & DOHME LLC·Filed 2024·Granted Dec 31, 2024·1 cites·8 claims
- 0595US11850278B2Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2021·Granted Dec 26, 2023·3 cites·2 claims
- 0695US11759523B2Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugatesMERCK SHARP & DOHME LLC·Filed 2022·Granted Sep 19, 2023·3 cites·20 claims
- 0795US11759510B2Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugatesMERCK SHARP & DOHME LLC·Filed 2022·Granted Sep 19, 2023·3 cites·20 claims
- 0895US11484565B2PCSK9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2020·Granted Nov 1, 2022·3 cites·18 claims
- 0994US11964023B2Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugatesMERCK SHARP & DOHME LLC·Filed 2022·Granted Apr 23, 2024·2 cites·21 claims
- 1093US11697657B2Small molecule inhibitors of KRAS G12C mutantMERCK SHARP & DOHME LLC·Filed 2020·Granted Jul 11, 2023·4 cites·22 claims
- 1192US11919894B2Pro drugs of PDE10 compoundsMERCK SHARP & DOHME LLC·Filed 2022·Granted Mar 5, 2024·2 cites·54 claims
- 1291US2025304588A1Process for preparing beta 3 agonists and intermediatesMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1390US12371478B2Antibody neutralizing human respiratory syncytial virusMERCK SHARP & DOHME LLC·Filed 2024·Granted Jul 29, 2025·0 cites·19 claims
- 1490US11773150B2Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptorsMERCK SHARP & DOHME LLC·Filed 2020·Granted Oct 3, 2023·2 cites·7 claims
- 1590US11759511B2Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugatesMERCK SHARP & DOHME LLC·Filed 2022·Granted Sep 19, 2023·1 cites·21 claims
- 1689US11883480B2Formulations of dengue virus vaccine compositionsMERCK SHARP & DOHME LLC·Filed 2022·Granted Jan 30, 2024·2 cites·8 claims
- 1788US12002202B2Meta-learning for cardiac MRI segmentationMERCK SHARP & DOHME LLC·Filed 2021·Granted Jun 4, 2024·5 cites·20 claims
- 1888US11633476B2Stable formulations of programmed death receptor 1 (PD-1) antibodies and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2018·Granted Apr 25, 2023·6 cites·21 claims
- 1988US2024300955A1Process for preparing beta 3 agonists and intermediatesMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2088US2025388654A1Antibody neutralizing human respiratory syncytial virusMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 2187US11547705B2Combination of a PD-1 antagonist and a VEGF-R/FGFR/RET tyrosine kinase inhibitor for treating cancerMERCK SHARP & DOHME LLC·Filed 2016·Granted Jan 10, 2023·4 cites·32 claims
- 2286US11884683B2Tricyclic heterocycle compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Jan 30, 2024·4 cites·17 claims
- 2386US2025064924A1Anti-tigit antibodiesMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 2485US12097250B2Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2023·Granted Sep 24, 2024·0 cites·9 claims
- 2585US11642406B2Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2019·Granted May 9, 2023·2 cites·9 claims
- 2685US11530244B2Cyclic polypeptides for PCSK9 inhibitionMERCK SHARP & DOHME LLC·Filed 2019·Granted Dec 20, 2022·6 cites·15 claims
- 2785US2026027206A1Stable formulations of programmed death receptor 1 (pd-1) antibodies and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 2885US2026027204A1Stable formulations of programmed death receptor 1 (pd-1) antibodies and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 2985US2026027205A1Stable formulations of programmed death receptor 1 (pd-1) antibodies and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 3084US12275800B2Anti-coagulation factor XI antibodiesMERCK SHARP & DOHME LLC·Filed 2023·Granted Apr 15, 2025·0 cites·18 claims
- 3184US12102680B2Anti-TIGIT antibodiesMERCK SHARP & DOHME LLC·Filed 2020·Granted Oct 1, 2024·1 cites·30 claims
- 3284US11981726B2Antibody neutralizing human respiratory syncytial virusMERCK SHARP & DOHME LLC·Filed 2022·Granted May 14, 2024·0 cites·16 claims
- 3384US11661460B2Anti-coagulation factor XI antibodiesMERCK SHARP & DOHME LLC·Filed 2020·Granted May 30, 2023·1 cites·67 claims
- 3483US12295998B2Enhancing immunogenicity of Streptococcus pneumoniae polysaccharide-protein conjugatesMERCK SHARP & DOHME LLC·Filed 2023·Granted May 13, 2025·0 cites·2 claims
- 3583US11702467B2High affinity antibodies targeting tau phosphorylated at serine 413MERCK SHARP & DOHME LLC·Filed 2021·Granted Jul 18, 2023·1 cites·33 claims
- 3683US11427616B2PCSK9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2019·Granted Aug 30, 2022·3 cites·48 claims
- 3783US2025073254A1Methods for treatment and prophylaxis of hiv and aidsMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 3883US2024398925A1Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 3982US12091405B2Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Sep 17, 2024·2 cites·13 claims
- 4082US11413352B2Conjugate based systems for controlled insulin deliveryMERCK SHARP & DOHME LLC·Filed 2018·Granted Aug 16, 2022·2 cites·3 claims
- 4182US2023041441A1Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugatesMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 4281US12344670B2Anti-ILT4 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME LLC·Filed 2023·Granted Jul 1, 2025·0 cites·10 claims
- 4381US12338219B2Antimalarial agentsMERCK SHARP & DOHME LLC·Filed 2020·Granted Jun 24, 2025·1 cites·16 claims
- 4481US12297208B2Small molecule inhibitors of KRAS G12C mutantMERCK SHARP & DOHME LLC·Filed 2023·Granted May 13, 2025·0 cites·18 claims
- 4581US12291538B2Small molecule inhibitors of KRAS G12C mutantMERCK SHARP & DOHME LLC·Filed 2023·Granted May 6, 2025·0 cites·6 claims
- 4681US12263171B27-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2019·Granted Apr 1, 2025·2 cites·20 claims
- 4781US12152019B2Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Nov 26, 2024·2 cites·20 claims
- 4881US12102681B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME LLC·Filed 2022·Granted Oct 1, 2024·0 cites·12 claims
- 4980US12331018B2Pyrrolidine orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2020·Granted Jun 17, 2025·1 cites·6 claims
- 5080US2023107713A1Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugatesMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
Showing the top 50 of 466 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →